{
  "k": 12,
  "inference_threshold": 0.4,
  "centroid_thresh_cat4": 0.15,
  "centroid_thresh_cat3": 0.25,
  "feature_order": [
    "age",
    "obs_bmi",
    "obs_systolic_bp",
    "obs_diastolic_bp",
    "obs_phq9_score",
    "obs_testosterone",
    "obs_smoker",
    "cond_migraine_with_aura",
    "cond_stroke",
    "cond_mi",
    "cond_dvt",
    "cond_breast_cancer",
    "cond_lupus",
    "cond_thrombophilia",
    "cond_atrial_fibrillation",
    "cond_liver_disease",
    "cond_hypertension",
    "cond_migraine",
    "cond_gallstones",
    "cond_diabetes",
    "cond_prediabetes",
    "cond_epilepsy",
    "cond_chronic_kidney_disease",
    "cond_sleep_apnea",
    "cond_pcos",
    "cond_endometriosis",
    "cond_depression",
    "cond_hypothyroidism",
    "cond_rheumatoid_arthritis",
    "cond_fibromyalgia",
    "cond_osteoporosis",
    "cond_asthma"
  ],
  "continuous_features": [
    "age",
    "obs_bmi",
    "obs_systolic_bp",
    "obs_diastolic_bp",
    "obs_phq9_score",
    "obs_testosterone"
  ],
  "binary_features": [
    "obs_smoker",
    "cond_migraine_with_aura",
    "cond_stroke",
    "cond_mi",
    "cond_dvt",
    "cond_breast_cancer",
    "cond_lupus",
    "cond_thrombophilia",
    "cond_atrial_fibrillation",
    "cond_liver_disease",
    "cond_hypertension",
    "cond_migraine",
    "cond_gallstones",
    "cond_diabetes",
    "cond_prediabetes",
    "cond_epilepsy",
    "cond_chronic_kidney_disease",
    "cond_sleep_apnea",
    "cond_pcos",
    "cond_endometriosis",
    "cond_depression",
    "cond_hypothyroidism",
    "cond_rheumatoid_arthritis",
    "cond_fibromyalgia",
    "cond_osteoporosis",
    "cond_asthma"
  ],
  "all_pill_ids": [
    "EE20_LNG90",
    "EE30_LNG150",
    "EE35_NET500_1000",
    "EE20_NET1000",
    "EE25_35_NGM",
    "EE30_DSG150",
    "EE30_DRSP3",
    "EE20_DRSP3",
    "NET_PO_350"
  ],
  "all_combined_ids": [
    "EE20_LNG90",
    "EE30_LNG150",
    "EE35_NET500_1000",
    "EE20_NET1000",
    "EE25_35_NGM",
    "EE30_DSG150",
    "EE30_DRSP3",
    "EE20_DRSP3"
  ],
  "profiles": {
    "0": {
      "label": "Profile 0: Rheum. Arthritis + Sleep Apnea",
      "n_patients_train": 14,
      "pct_train": 0.3,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 42.9%]"
        ],
        "NET_PO_350": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 21.4%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000",
        "NET_PO_350"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_rheumatoid_arthritis",
          "label": "Rheum. Arthritis",
          "cluster_mean": 0.3571,
          "pop_mean": 0.0012,
          "elevation": 0.3559
        },
        {
          "feature": "cond_sleep_apnea",
          "label": "Sleep Apnea",
          "cluster_mean": 0.3571,
          "pop_mean": 0.0019,
          "elevation": 0.3552
        },
        {
          "feature": "cond_hypertension",
          "label": "Hypertension",
          "cluster_mean": 0.4286,
          "pop_mean": 0.0933,
          "elevation": 0.3353
        },
        {
          "feature": "cond_endometriosis",
          "label": "Endometriosis",
          "cluster_mean": 0.3571,
          "pop_mean": 0.0663,
          "elevation": 0.2908
        },
        {
          "feature": "cond_breast_cancer",
          "label": "Breast Cancer",
          "cluster_mean": 0.2143,
          "pop_mean": 0.0085,
          "elevation": 0.2058
        },
        {
          "feature": "cond_depression",
          "label": "Depression",
          "cluster_mean": 0.2857,
          "pop_mean": 0.0831,
          "elevation": 0.2026
        },
        {
          "feature": "cond_diabetes",
          "label": "Diabetes",
          "cluster_mean": 0.1429,
          "pop_mean": 0.0221,
          "elevation": 0.1208
        },
        {
          "feature": "cond_migraine",
          "label": "Migraine",
          "cluster_mean": 0.2143,
          "pop_mean": 0.102,
          "elevation": 0.1123
        }
      ],
      "centroid": {
        "age": 44.2697,
        "obs_bmi": 28.6286,
        "obs_systolic_bp": 129.3571,
        "obs_diastolic_bp": 87.0,
        "obs_phq9_score": 12.2143,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0714,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.2143,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.4286,
        "cond_migraine": 0.2143,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.1429,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.3571,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.3571,
        "cond_depression": 0.2857,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.3571,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "1": {
      "label": "Profile 1: Migraine + Depression",
      "n_patients_train": 661,
      "pct_train": 16.1,
      "blocked_combos": {},
      "all_blocked_ids": [],
      "top_elevated_features": [
        {
          "feature": "cond_migraine",
          "label": "Migraine",
          "cluster_mean": 0.463,
          "pop_mean": 0.102,
          "elevation": 0.3609
        },
        {
          "feature": "cond_depression",
          "label": "Depression",
          "cluster_mean": 0.354,
          "pop_mean": 0.0831,
          "elevation": 0.2709
        },
        {
          "feature": "cond_endometriosis",
          "label": "Endometriosis",
          "cluster_mean": 0.2784,
          "pop_mean": 0.0663,
          "elevation": 0.2121
        }
      ],
      "centroid": {
        "age": 35.7495,
        "obs_bmi": 27.9714,
        "obs_systolic_bp": 118.9289,
        "obs_diastolic_bp": 78.505,
        "obs_phq9_score": 14.0892,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.0,
        "cond_migraine": 0.463,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.0,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.2784,
        "cond_depression": 0.354,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "2": {
      "label": "Profile 2: Diabetes + Breast Cancer",
      "n_patients_train": 66,
      "pct_train": 1.6,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 52.8%]"
        ],
        "NET_PO_350": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 45.6%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000",
        "NET_PO_350"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_diabetes",
          "label": "Diabetes",
          "cluster_mean": 0.5283,
          "pop_mean": 0.0221,
          "elevation": 0.5062
        },
        {
          "feature": "cond_breast_cancer",
          "label": "Breast Cancer",
          "cluster_mean": 0.4564,
          "pop_mean": 0.0085,
          "elevation": 0.4479
        },
        {
          "feature": "cond_depression",
          "label": "Depression",
          "cluster_mean": 0.1826,
          "pop_mean": 0.0831,
          "elevation": 0.0995
        },
        {
          "feature": "cond_migraine",
          "label": "Migraine",
          "cluster_mean": 0.1804,
          "pop_mean": 0.102,
          "elevation": 0.0783
        },
        {
          "feature": "cond_hypertension",
          "label": "Hypertension",
          "cluster_mean": 0.1514,
          "pop_mean": 0.0933,
          "elevation": 0.0581
        }
      ],
      "centroid": {
        "age": 41.1385,
        "obs_bmi": 27.9912,
        "obs_systolic_bp": 119.2237,
        "obs_diastolic_bp": 79.8144,
        "obs_phq9_score": 14.0063,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.4564,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0457,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.1514,
        "cond_migraine": 0.1804,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.5283,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0152,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.0,
        "cond_depression": 0.1826,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "3": {
      "label": "Profile 3: Hypertension + Diabetes",
      "n_patients_train": 57,
      "pct_train": 1.4,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 100.0%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 56.0%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_hypertension",
          "label": "Hypertension",
          "cluster_mean": 1.0,
          "pop_mean": 0.0933,
          "elevation": 0.9067
        },
        {
          "feature": "cond_diabetes",
          "label": "Diabetes",
          "cluster_mean": 0.5604,
          "pop_mean": 0.0221,
          "elevation": 0.5383
        },
        {
          "feature": "cond_endometriosis",
          "label": "Endometriosis",
          "cluster_mean": 0.4028,
          "pop_mean": 0.0663,
          "elevation": 0.3365
        },
        {
          "feature": "cond_epilepsy",
          "label": "Epilepsy",
          "cluster_mean": 0.1051,
          "pop_mean": 0.0211,
          "elevation": 0.0839
        },
        {
          "feature": "cond_migraine_with_aura",
          "label": "Migraine+Aura",
          "cluster_mean": 0.1051,
          "pop_mean": 0.0425,
          "elevation": 0.0626
        }
      ],
      "centroid": {
        "age": 41.9285,
        "obs_bmi": 28.7588,
        "obs_systolic_bp": 120.1232,
        "obs_diastolic_bp": 82.194,
        "obs_phq9_score": 12.8248,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.1051,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 1.0,
        "cond_migraine": 0.0,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.5604,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.1051,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.035,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.4028,
        "cond_depression": 0.0,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "4": {
      "label": "Profile 4: Thrombophilia + Endometriosis",
      "n_patients_train": 138,
      "pct_train": 3.4,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 83.3%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_thrombophilia",
          "label": "Thrombophilia",
          "cluster_mean": 0.8333,
          "pop_mean": 0.0352,
          "elevation": 0.7981
        },
        {
          "feature": "cond_endometriosis",
          "label": "Endometriosis",
          "cluster_mean": 0.1739,
          "pop_mean": 0.0663,
          "elevation": 0.1076
        },
        {
          "feature": "cond_migraine_with_aura",
          "label": "Migraine+Aura",
          "cluster_mean": 0.1449,
          "pop_mean": 0.0425,
          "elevation": 0.1024
        },
        {
          "feature": "cond_epilepsy",
          "label": "Epilepsy",
          "cluster_mean": 0.0942,
          "pop_mean": 0.0211,
          "elevation": 0.0731
        },
        {
          "feature": "cond_depression",
          "label": "Depression",
          "cluster_mean": 0.1377,
          "pop_mean": 0.0831,
          "elevation": 0.0546
        }
      ],
      "centroid": {
        "age": 37.0157,
        "obs_bmi": 27.9934,
        "obs_systolic_bp": 118.8628,
        "obs_diastolic_bp": 77.6047,
        "obs_phq9_score": 14.3842,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.1449,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.8333,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.0,
        "cond_migraine": 0.1232,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.0,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0942,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.1739,
        "cond_depression": 0.1377,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "5": {
      "label": "Profile 5: Baseline / Low-Risk",
      "n_patients_train": 2403,
      "pct_train": 58.4,
      "blocked_combos": {},
      "all_blocked_ids": [],
      "top_elevated_features": [],
      "centroid": {
        "age": 29.6032,
        "obs_bmi": 26.4091,
        "obs_systolic_bp": 118.7062,
        "obs_diastolic_bp": 78.7045,
        "obs_phq9_score": 13.8926,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.0,
        "cond_migraine": 0.0,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.0,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.0,
        "cond_depression": 0.0,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "6": {
      "label": "Profile 6: PCOS + Thrombophilia",
      "n_patients_train": 13,
      "pct_train": 0.3,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]",
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 46.1%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 30.8%]",
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 38.4%]"
        ],
        "NET_PO_350": [
          "WHO MEC Cat 4: Breast cancer \u2014 all hormonal OCPs contraindicated (WHO MEC Cat 4) [profile prevalence: 15.4%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000",
        "NET_PO_350"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_pcos",
          "label": "PCOS",
          "cluster_mean": 1.0,
          "pop_mean": 0.0787,
          "elevation": 0.9213
        },
        {
          "feature": "cond_thrombophilia",
          "label": "Thrombophilia",
          "cluster_mean": 0.461,
          "pop_mean": 0.0352,
          "elevation": 0.4258
        },
        {
          "feature": "cond_epilepsy",
          "label": "Epilepsy",
          "cluster_mean": 0.3841,
          "pop_mean": 0.0211,
          "elevation": 0.363
        },
        {
          "feature": "cond_hypertension",
          "label": "Hypertension",
          "cluster_mean": 0.3075,
          "pop_mean": 0.0933,
          "elevation": 0.2142
        },
        {
          "feature": "cond_breast_cancer",
          "label": "Breast Cancer",
          "cluster_mean": 0.1536,
          "pop_mean": 0.0085,
          "elevation": 0.1451
        },
        {
          "feature": "cond_migraine",
          "label": "Migraine",
          "cluster_mean": 0.2314,
          "pop_mean": 0.102,
          "elevation": 0.1294
        },
        {
          "feature": "cond_migraine_with_aura",
          "label": "Migraine+Aura",
          "cluster_mean": 0.1538,
          "pop_mean": 0.0425,
          "elevation": 0.1113
        },
        {
          "feature": "cond_atrial_fibrillation",
          "label": "Afib",
          "cluster_mean": 0.0768,
          "pop_mean": 0.0002,
          "elevation": 0.0766
        }
      ],
      "centroid": {
        "age": 35.7037,
        "obs_bmi": 26.0971,
        "obs_systolic_bp": 119.1597,
        "obs_diastolic_bp": 79.3786,
        "obs_phq9_score": 13.6157,
        "obs_testosterone": 84.8096,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.1538,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.1536,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.461,
        "cond_atrial_fibrillation": 0.0768,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.3075,
        "cond_migraine": 0.2314,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.0,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.3841,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 1.0,
        "cond_endometriosis": 0.0,
        "cond_depression": 0.0,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "7": {
      "label": "Profile 7: Epilepsy",
      "n_patients_train": 65,
      "pct_train": 1.6,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 3: Epilepsy / AED interaction \u2014 enzyme-inducing AEDs reduce OCP efficacy (WHO MEC Cat 3 interaction) [profile prevalence: 95.4%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_epilepsy",
          "label": "Epilepsy",
          "cluster_mean": 0.9538,
          "pop_mean": 0.0211,
          "elevation": 0.9327
        }
      ],
      "centroid": {
        "age": 30.9146,
        "obs_bmi": 24.2077,
        "obs_systolic_bp": 119.0554,
        "obs_diastolic_bp": 79.0015,
        "obs_phq9_score": 13.7231,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.0,
        "cond_migraine": 0.0,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.0,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.9538,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.0,
        "cond_depression": 0.0,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0154,
        "cond_osteoporosis": 0.0462,
        "cond_asthma": 0.0
      }
    },
    "8": {
      "label": "Profile 8: PCOS + Hypertension",
      "n_patients_train": 72,
      "pct_train": 1.7,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 62.5%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_pcos",
          "label": "PCOS",
          "cluster_mean": 1.0,
          "pop_mean": 0.0787,
          "elevation": 0.9213
        },
        {
          "feature": "cond_hypertension",
          "label": "Hypertension",
          "cluster_mean": 0.6251,
          "pop_mean": 0.0933,
          "elevation": 0.5318
        },
        {
          "feature": "cond_migraine",
          "label": "Migraine",
          "cluster_mean": 0.4999,
          "pop_mean": 0.102,
          "elevation": 0.3979
        },
        {
          "feature": "cond_diabetes",
          "label": "Diabetes",
          "cluster_mean": 0.1806,
          "pop_mean": 0.0221,
          "elevation": 0.1585
        },
        {
          "feature": "cond_depression",
          "label": "Depression",
          "cluster_mean": 0.125,
          "pop_mean": 0.0831,
          "elevation": 0.042
        },
        {
          "feature": "cond_migraine_with_aura",
          "label": "Migraine+Aura",
          "cluster_mean": 0.0694,
          "pop_mean": 0.0425,
          "elevation": 0.0269
        }
      ],
      "centroid": {
        "age": 40.3692,
        "obs_bmi": 29.1985,
        "obs_systolic_bp": 122.9167,
        "obs_diastolic_bp": 83.6407,
        "obs_phq9_score": 13.875,
        "obs_testosterone": 99.2131,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0694,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.6251,
        "cond_migraine": 0.4999,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.1806,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 1.0,
        "cond_endometriosis": 0.0834,
        "cond_depression": 0.125,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "9": {
      "label": "Profile 9: PCOS",
      "n_patients_train": 239,
      "pct_train": 5.8,
      "blocked_combos": {},
      "all_blocked_ids": [],
      "top_elevated_features": [
        {
          "feature": "cond_pcos",
          "label": "PCOS",
          "cluster_mean": 1.0,
          "pop_mean": 0.0787,
          "elevation": 0.9213
        }
      ],
      "centroid": {
        "age": 34.2504,
        "obs_bmi": 27.9983,
        "obs_systolic_bp": 119.6945,
        "obs_diastolic_bp": 78.7197,
        "obs_phq9_score": 13.9414,
        "obs_testosterone": 101.1067,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0586,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0377,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.0,
        "cond_migraine": 0.0,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.0,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0042,
        "cond_pcos": 1.0,
        "cond_endometriosis": 0.0921,
        "cond_depression": 0.1046,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "10": {
      "label": "Profile 10: Hypertension + Migraine+Aura",
      "n_patients_train": 360,
      "pct_train": 8.7,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 4: Migraine with aura \u2014 estrogen \u2191 ischemic stroke risk (WHO MEC Cat 4) [profile prevalence: 34.7%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 68.3%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_hypertension",
          "label": "Hypertension",
          "cluster_mean": 0.6832,
          "pop_mean": 0.0933,
          "elevation": 0.5899
        },
        {
          "feature": "cond_migraine_with_aura",
          "label": "Migraine+Aura",
          "cluster_mean": 0.3473,
          "pop_mean": 0.0425,
          "elevation": 0.3048
        }
      ],
      "centroid": {
        "age": 39.0919,
        "obs_bmi": 28.6819,
        "obs_systolic_bp": 122.4571,
        "obs_diastolic_bp": 83.1135,
        "obs_phq9_score": 14.0809,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.3473,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.0,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.6832,
        "cond_migraine": 0.1028,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.0,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.0,
        "cond_depression": 0.1084,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.0
      }
    },
    "11": {
      "label": "Profile 11: Hypertension + Thrombophilia",
      "n_patients_train": 29,
      "pct_train": 0.7,
      "blocked_combos": {
        "EE20_LNG90": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ],
        "EE30_LNG150": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ],
        "EE35_NET500_1000": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ],
        "EE20_NET1000": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ],
        "EE25_35_NGM": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ],
        "EE30_DSG150": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ],
        "EE30_DRSP3": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ],
        "EE20_DRSP3": [
          "WHO MEC Cat 4: Hereditary thrombophilia \u2014 VTE risk \u00d78.4 with estrogen (Bloemenkamp Lancet 1995; WHO MEC Cat 4) [profile prevalence: 41.0%]",
          "WHO MEC Cat 3: Hypertension \u2014 elevated CVD risk with estrogen (WHO MEC Cat 3) [profile prevalence: 54.8%]",
          "WHO MEC Cat 3: Diabetes \u2014 vascular risk compounded by estrogen (WHO MEC Cat 3) [profile prevalence: 31.7%]"
        ]
      },
      "all_blocked_ids": [
        "EE20_DRSP3",
        "EE20_LNG90",
        "EE20_NET1000",
        "EE25_35_NGM",
        "EE30_DRSP3",
        "EE30_DSG150",
        "EE30_LNG150",
        "EE35_NET500_1000"
      ],
      "top_elevated_features": [
        {
          "feature": "cond_hypertension",
          "label": "Hypertension",
          "cluster_mean": 0.5481,
          "pop_mean": 0.0933,
          "elevation": 0.4548
        },
        {
          "feature": "cond_thrombophilia",
          "label": "Thrombophilia",
          "cluster_mean": 0.41,
          "pop_mean": 0.0352,
          "elevation": 0.3748
        },
        {
          "feature": "cond_diabetes",
          "label": "Diabetes",
          "cluster_mean": 0.3167,
          "pop_mean": 0.0221,
          "elevation": 0.2946
        },
        {
          "feature": "cond_endometriosis",
          "label": "Endometriosis",
          "cluster_mean": 0.3075,
          "pop_mean": 0.0663,
          "elevation": 0.2411
        },
        {
          "feature": "cond_asthma",
          "label": "cond_asthma",
          "cluster_mean": 0.239,
          "pop_mean": 0.0017,
          "elevation": 0.2373
        },
        {
          "feature": "cond_migraine",
          "label": "Migraine",
          "cluster_mean": 0.2101,
          "pop_mean": 0.102,
          "elevation": 0.1081
        },
        {
          "feature": "cond_migraine_with_aura",
          "label": "Migraine+Aura",
          "cluster_mean": 0.0683,
          "pop_mean": 0.0425,
          "elevation": 0.0258
        }
      ],
      "centroid": {
        "age": 41.1637,
        "obs_bmi": 28.6414,
        "obs_systolic_bp": 125.2266,
        "obs_diastolic_bp": 88.5452,
        "obs_phq9_score": 13.8486,
        "obs_testosterone": 99.8,
        "obs_smoker": 0.0,
        "cond_migraine_with_aura": 0.0683,
        "cond_stroke": 0.0,
        "cond_mi": 0.0,
        "cond_dvt": 0.0,
        "cond_breast_cancer": 0.0,
        "cond_lupus": 0.0,
        "cond_thrombophilia": 0.41,
        "cond_atrial_fibrillation": 0.0,
        "cond_liver_disease": 0.0,
        "cond_hypertension": 0.5481,
        "cond_migraine": 0.2101,
        "cond_gallstones": 0.0,
        "cond_diabetes": 0.3167,
        "cond_prediabetes": 0.0,
        "cond_epilepsy": 0.0,
        "cond_chronic_kidney_disease": 0.0,
        "cond_sleep_apnea": 0.0,
        "cond_pcos": 0.0,
        "cond_endometriosis": 0.3075,
        "cond_depression": 0.0,
        "cond_hypothyroidism": 0.0,
        "cond_rheumatoid_arthritis": 0.0,
        "cond_fibromyalgia": 0.0,
        "cond_osteoporosis": 0.0,
        "cond_asthma": 0.239
      }
    }
  }
}